| A.1 |
Using selective reaction monitoring (SRM) mass spectrometry to unmask regulatory feedback loops controlling adipogenesis.
R. Ahrends*, E. Abell, .B., O, Park, M.N. Teruel |
| A.2 |
Identification and characterization of intact proteins in complex mixtures using online fragmentation on the Orbitrap Elite hybrid mass spectrometer.
S. Eliuk*, J. F. Kellie, D. Horn, N. Kelleher, V. Zabrouskov |
| A.3 |
Differential recovery of peptides from sample tubes and the reproducibility of quantitative proteomic data.
M. Ghassemian*, G. Newton, E. Komives |
| A.4 |
Increasing LCMS assay robustness through increased specificity using high resolution MRM-like analysis.
C. Hunter*, H. Keshishian, S.A. Carr |
| A.5 |
Mapping of disulfide bonds in an insulin analogue containing an additional 7th cysteine residue.
T. Nygaard Vinther*, K. J. Jensen, T. B. Kjeldsen, F. Hubálek |
| A.6 |
Investigating nuclear pore composition using targeted proteomics.
A. Ori*, A. Andres-Pons, N. Banterle, L. Sparks, M. Beck |
| A.7 |
Conserved peptide sequences that bind to the surface of Plasmodium berghei ookinetes.
V. Pando*, J. Hernández-Romano, M.H. Rodríguez, J. A. Torres-Monzón, A. Alvarado-Delgado, A. Lecona -Valera, R. Argotte-Ramos, J. Martínez-Barnetche, M. C. Rodríguez |
| A.8 |
Characterization of a Taenia solium immunogenic protein complex with cathepsin L-like activity using proteomics.
V. Pando*, D. Rueda, R. Piña, R.H. Gilman, A. Gutierrez, M. Flores, C. Sifuentes, P. Sheen, D. Kirwan, S. Rodriguez, H. H. García, M. Zimic |
| A.9 |
Proteome of Crotalus basiliscus and identification of immunogens for antivenom manufacture.
V. Pando*, C. Ortega, S.M.T. Serrano, A. Zelanis, E. Kitano, H Lanz, ME Jiménez, F. Reta, BE García, J. Luna |
| A.10 |
Proteomic analysis of regenerating sensory axons.
M. Rajman*, K. F. Medzihradszky, A. L., M. Fainzilber |
| A.11 |
Carbohydrate chains contribute to deuterium retention on glycopeptides in hydrogen deuterium exchange experiments.
M. Guttman*, M. Scian, K. K. Lee |
| A.12 |
Alph-lytic protease: orthogonal specificity complementary to trypsin for proteomics.
E. Komives* and J.G. Meyer |
| A.13 |
Deletion network analysis for capturing protein complex architecture and protein function.
M. Washburn*, K. Lee, J. Gilmore, M. Sardiu, S. Swanson, M.l Torok, S. Venkatesh |
| A.14 |
Phosphoproteomic analysis of microsomal fractions of Imperata cylindrica revealed novel phosphorylation sites.
Ing-Feng Chang*, Ting Ying Wu, Tsung-Ju Hsieh |
| A.15 |
iTRAQ-based proteomic study of the effects of microcystin-LR on medaka fish liver.
Marc Edery*, Mélodie Malécot, Arul Marie, Simone Puiseux-Dao |
| B.1 |
Hydrogen-deuterium exchange mass spectrometry used to identify allosterically relevant changes in pyruvate kinase.
C. B. Prasannan, A. Artigues*, A. W. Fenton |
| B.2 |
Characterizing DNA damage signaling in melanoma following MEK and PI3K dual inhibition.
D. Bustos*, C. E. Bakalarski, J. Chan, T. Dogan, K. Yu, M. Belvin, L. S. Friedman, K. P. Hoeflich, D. S. Kirkpatrick |
| B.3 |
Proteomic analysis of pentraxin3 (PTX3) complexes in serum and plasma from septic patients reveals that the neutrophil extracellular traps components are the new PTX3 ligands.
Kenji Daigo*, N. Yamaguchi, T. Kawamura, Y. Sudou, K. Inoue, T. Hamakubo |
| B.4 |
Characterizing mitochondrial proteomes in primary leukaemic cells and cell lines.
J. Langridge*, T. McKenna, J. B. Connolly, R. Jukes-Jones, C. Langlais, K. Cain |
| B.5 |
Quantitative phosphoproteomic analysis reveals a role for serine and threonine kinases in the cytoskeleton reorganization in early TCR activation in human primary T cells.
P. Ruperez*, J.A. Oses Prieto, A. Gago-Martinez, A. L. Burlingame |
| B.6 |
15N-labeled protein standards and MRM assay for membrane proteins.
M. Wang*, G-Y. Heo, I. A. Pikuleva, I. V. Turko |
| B.7 |
Investigation of proteolytic cleavage at modified residues.
Q. Phung*, T. Cheung, J. Lill |
| B.8 |
Classification of common contaminants in LCMSMS based proteomics experiments.
J. Chen*, M. Trnka, S. Guan, A. L. Burlingame |
| B.9 |
PTMSCAN Direct: A method for identification and quantification of critical signaling nodes.
J.C. Silva*, M. P. Stokes, C. L. Farnsworth, X. Jia, A. Mortiz, A. Guo, M. Comb, J. Rush, Ro |
| B.10 |
Protein database construction for microbial community proteomics and impacts on peptide and protein assignments, confidence, quantitation and differential analysis.
M. Hackett*, D. A. C. Beck, E. L. Hendrickson, T. Wang |
| B.11 |
Proteomic and transcriptomic correlations for microbial species: Methanococcus maripaludis, Methylotenera mobilis and Porphyromonas gingivalis.
E. L. Hendrickson, D. A. C. Beck, T. Wang, S-H. Yoon, L. Chistoserdova, N. S. Baliga, R. J. Lamont, J. A. Leigh, M. Hackett * |
| B.12 |
HRI eIF2α kinase: A global assessment of its protein translational regulation in mouse hepatocytes.
Y. Liu*, S. Guan, Y-Q. Wang, A. L. Burlingame, M. Almira Correia. |
| B.13 |
Mapping the yeast N-glycoproteome with isotopically recoded glycans.
K. Palaniappan*, M. Breidenbach., C. Bertozzi. |
| B.14 |
Differential carbonylation of proteins as a function of in vivo oxidative stress.
A. G. Madian*, A. D. Myracle, N. Diaz-Maldonado, N. S. Rochelle, E. M. Janle, Fred E. Regnier |
| B.15 |
Mass Spectrometry Analysis of Cytosolic and Nuclear Proteins of Human CD34+ Hematopoietic Progenitor Cells, Myeloid Leukemia Cell Line KG1 and Mature Human Neutrophils.
Ruta Navakauskiene*, V. Borutinskaite, G. Treigyte, J. Savickiene, D. Matuzevicius, K.-E. Magnusson, D.Navakauskas |
| C.1 |
Identification of activity markers of kinases targeted by MEK, JAK and PI3K inhibitors.
P. Cutillas* |
| C.2 |
The use of nitric oxide as a radiosensitiser of hypoxic prostate cancer characterized by data independent label-free ion mobility LC-MS.
R. Martin*, G. D Stewart, J. Nanda, F. K Habib, C. Dorschel, J. PC Vissers, J. Ross |
| C.3 |
MS/MS analysis of sulfo- and glycopeptides: a practical view.
K. Medzihradsky* and Z. Darula |
| C.4 |
Analyzing human protein interaction networks with multifunctional affinity tags.
D. Daniels, J. Mendez, A. Mosley, S. Ramisetty, N. Murphy, H. Benink, K. Wood, M. Urh* |
| C.5 |
Enhanced sequencing of non-tryptic peptides by electron-transfer dissociation.
J. Meyer* and E. Komives |
| C.6 |
LymPhos database: A compendium of primary human T-cells phosphoproteome.
Emilio Gelpi*, M. Carrascal, M. Gay, O. Gallardo, V. Casas, J. Abián |
| C.7 |
ISDetect: A rapid and universal approach to the verification of protein termini.
Y. Gan*, C. E. Bakalarski, F. Yan, L. Zhu, J. Lill, W. Sandoval |
| C.8 |
Complexity, information, and the proteomes.
J. Sherman*, M. Molloy, Al Burlingame |
| C.9 |
Quantitative proteomics reveals the compensatory islet proteome response to insulin resistance.
J. Zhou*, C-W, Liew, T. RW Clauss, D. G. Camp II, R. D. Smith, R. N. Kulkarni, W-J. Qian |
| C.10 |
Discovering and profiling caspase-derived peptides in cultured cell lines by SRM to identify cell-type and chemotherapy-specific biomarkers of apoptosis.
K. Shimbo*, G. W. Hsu, S. Mahrus, H. Nguyen, J. C. Trinidad, D. Maltby, A. L. Burlingame, J. A. Wells |
| C.11 |
Systematic profiling of in vivo protein-protein interactions in transgenic mice.
L. Phu*, J. Wu, C. Bakalarski, A. Dey, D. Dugger, G. Lee, V. Pham, H. Zhu, K. Yu, J. R. Lill, K. Newton, V. M. Dixit, D. S. Kirkpatrick |
| C.12 |
The structure of early folding intermediates of mitochondrial aspartate aminotransferase and its reduced form..
M. Villar* and A. Artigues |
| C.13 |
Quantifying the impact of human respiratory syncytial virus on cellular proteins by mass spectrometry.
K. Dave*, T. A. Reeks, E. L. Redhead, K. M. Spann, M. L. Hastie, M. J. Headlam, A. A. Bukreyev, P. L. Collins, J. J. Gorman |
| C.14 |
Discovering Hg and Se peptides in whole proteomes using natural isotope distributions observed in LC-MS/MS.
B. Polacco*, S. O. Purvine, E. M. Zink, S. P. LaVoie, M. S. Lipton, A. O. Summers, S. M. Miller |
| C.15 |
Glycoprotein profiling of breast cancer cell lines.
Ten-Yang Yen*, Judi Wong, Chris Alleyne-Chin, Christina Litsakos-Cheung, Roger Yen, Leslie Timpe, Bruce A Macher |
